logo dark logo light logo
  • Solutions
    • Modelling and Simulation
      • Mechanism of Action Modelling
      • Exposure Response Modelling
      • Translational Modelling
      • Tumour Growth Inhibition Modelling
      • Population PK and NCA
      • PBPK Modelling
      • Clinical Trial Simulation
    • Biostatistics
    • Data Science & Bioinformatics
  • Virtual Tumour
  • Precision Oncology
  • Resources
    • Scientific Content
    • Investor Content
    • FAQs
  • News
    • All News
    • Investor News / RNS
    • Blog
    • Events
  • AIM Rule 26
    • Share Information
    • Investor News / RNS
    • Board of Directors
    • Advisors
    • Corporate Governance
    • Financial Reports
    • Corporate Documents
    • Registration
  • About Us
    • Partners
    • Team
    • Careers
  • Contact
logo dark logo light logo
  • Solutions
    • Modelling and Simulation
      • Mechanism of Action Modelling
      • Exposure Response Modelling
      • Translational Modelling
      • Tumour Growth Inhibition Modelling
      • Population PK and NCA
      • PBPK Modelling
      • Clinical Trial Simulation
    • Biostatistics
    • Data Science & Bioinformatics
  • Virtual Tumour
  • Precision Oncology
  • Resources
    • Scientific Content
    • Investor Content
    • FAQs
  • News
    • All News
    • Investor News / RNS
    • Blog
    • Events
  • AIM Rule 26
    • Share Information
    • Investor News / RNS
    • Board of Directors
    • Advisors
    • Corporate Governance
    • Financial Reports
    • Corporate Documents
    • Registration
  • About Us
    • Partners
    • Team
    • Careers
  • Contact
mobile-logo
  • Solutions
    • Modelling and Simulation
      • Mechanism of Action Modelling
      • Exposure Response Modelling
      • Translational Modelling
      • Tumour Growth Inhibition Modelling
      • Population PK and NCA
      • PBPK Modelling
      • Clinical Trial Simulation
    • Biostatistics
    • Data Science & Bioinformatics
  • Virtual Tumour
  • Precision Oncology
  • Resources
    • Scientific Content
    • Investor Content
    • FAQs
  • News
    • All News
    • Investor News / RNS
    • Blog
    • Events
  • AIM Rule 26
    • Share Information
    • Investor News / RNS
    • Board of Directors
    • Advisors
    • Corporate Governance
    • Financial Reports
    • Corporate Documents
    • Registration
  • About Us
    • Partners
    • Team
    • Careers
  • Contact
 

Sitemap

Sitemap

  • Virtual Tumour
  • Physiomics Brings Insight To Your Oncology Data
  • Join us at EORTC
    • Contact
  • 37th Annual Meeting of the Society for Immunotherapy of Cancer
  • Services
  • Solutions
    • Modelling and Simulation
      • Exposure Response Modelling
      • Mechanism of Action Modelling
      • PBPK Modelling
      • Tumour Growth Inhibition Modelling
      • Translational Modelling
      • Population PK and NCA
      • Clinical Trial Simulation
    • Biostatistics
    • Data Science and Bioinformatics
  • Precision Oncology
  • Resources
    • FAQs
    • Investor Content
  • All News
  • AIM Rule 26
    • Board of Directors
    • Advisors
    • Corporate Governance
      • Key QCA Principles
      • 2024 AGM Voting
    • Investor News / RNS
    • Registration
    • Financial Reports
    • Corporate Documents
    • Share Information
  • About Us
    • Team
      • Anthony Clayden
      • Dr Frances Brightman
      • Dr Claire Villette
      • Dr Hitesh Mistry
      • Professor David Fell
      • Dr Robert Jackson
      • Professor Mark Middleton
      • Charmaine Fraser
      • Dr Paul Harper
      • Hayley Close
      • Dr Misba Beerahee
      • Emily Hatchwell
      • Dr Michael Ghebre
      • Dr Jim Millen
      • Dr Mark Davies
      • Mr Shalabh Kumar
      • Dr Christophe Chassagnole
      • Dr Léa Sta
      • Dr Tim Corn
      • Dr Peter Sargent
    • Partners
    • Careers
  • Contact
  • Home
  • Home
  • Legal and Privacy Policy
  • Sitemap

logo

Physiomics Plc

Bee House

140 Eastern Avenue

Milton Park

Oxfordshire, OX14 4SB

United Kingdom

Email: info@physiomics.co.uk

Phone: +44 (0) 1235 841575

Quick Links

  • About
  • R&D Services
  • Resources
  • All News
  • Blog
  • AIM Rule 26
  • Legal & Privacy Policy
  • Sitemap
  • Contact
Newsletter
Receive news and updates from Physiomics. Select your interest below:
Corporate
Scientific

Copyright © Physiomics Plc 2025. Physiomics® is a registered trademark of Physiomics Plc.